The aim of this journal is to systematically provide expert views on current basic science and clinical advances in the field of atherosclerosis and highlight the most important developments likely to transform the field of cardiovascular prevention, diagnosis, and treatment. 

We accomplish this aim by appointing major authorities to serve as Section Editors who select leading experts from around the world to provide definitive reviews on key topics and papers published in the past year. We also provide supplementary reviews and commentaries from well-known figures in the field. An Editorial Board of internationally diverse members suggests topics of special interest to their country/region and ensures that topics are current and include emerging research.

Editor-in-Chief:
Antonio M. Gotto Jr, MD, DPhil (Weill Cornell Medical College, New York, New York, USA)

Associate Editor:
Anders G. Olsson, MD, PhD (University Hospital, Linköping, Sweden)


Editorial Board:
Jassim Al Suwaidi, MBChB, BAO, LRCP & SI (Hamad Medical Center, Doha, Qatar) 
Gerd Assmann, MD (Institut fur Arterioskleroseforschung, Munster, Germany) 
Jan Breslow, MD (Rockefeller University, New York, New York, USA) 
Rafael Carmena, MD, PhD, FACP, FRCP (University of Valencia, Valencia, Spain) 
Richard Ceska, MD,PhD, FEFIM (University General Hospital Prague, Prague, Czech Republic) 
Ada Cuevas, Md, MSc (Clinica Las Condes, Santiago, Chile) 
Jean-Charles Fruchart, PhD (Institute Pasteur de Lille, Lille, France) 
David P. Hajjar, PhD (Weill Cornell Medical College, New York, New York, USA) 
Jay Heinecke, MD (University of Washington, Seattle, Washington, USA) 
Katsu Ikewaki, MD (Jikei University School of Medicine, Tokyo, Japan) 
Eran Leitersdorf, MD (The Hebrew University of Jersusalem, Jerusalem, Israel) 
Peter Libby, MD (Brigham and Women's Hospital, Boston, Massachusetts, USA) 
Masanori Matsuzaki, PhD (Yamaguchi University, Yamaguchi, Japan) 
Emilio Moriguchi, MD, PhD (Federal University of Rio Grande do Sul School of Medicine, Porte Alegre, Brazil) 
Rodolfo Paoletti, MD, PhD (University of Milan, Milan, Italy) 
Raul Santos, MD (University of São Paulo Medical Center, São Paulo, Brazil) 
Attilio Rigotti, MD, PhD (Pontifical Catholic University of Chile, Santiago, Chile) 
Alan R. Tall, MD (Columbia University College of Physicians and Surgeons, New York, New York, USA) 
Marja-Riitta Taskinen, MD, PhD (Helsinki University Central Hospital, Helsinki, Finland) 
Lale Tokgözoglu, MD, FACC, FESC (Hacettepe University, Ankara, Turkey) 
Andrew Tonkin, MD, FRACP (Monash University, Melbourne, Victoria, Australia)
2019 Sections and Section Editors:
Coronary Heart Disease 
Global Coronary Heart Disease
Salim Virani, MBBS, PhD (Baylor College of Medicine, Houston, Texas, USA)
Sahar Naderi, MD (Massachusetts General Hospital, Boston, Massachusetts, USA)

Genetics and Genomics
Ali J. Marian, MD (University of Texas Health Science Center, Houston, Texas, USA)

Vascular Biology
James Hamilton, MD (Boston University School of Medicine, Boston, Massachusetts, USA)

Cardiovascular Disease and Stroke 
Shyam Prabhakaran, MD, MS (University of Chicago, Chicago, Illinois, USA)

Nutrition
Penny Kris-Etherton, PhD, RD (Pennsylvania State University, State College, Pennsylvania, USA)
Kristina Petersen, PhD, BNutDiet(Hons), APD (Pennsylvania State University, State College, Pennsylvania, USA)

Lipid and Metabolic Effects of Gastrointestinal Surgery
Ricardo Cohen, MD, PhD (Hospital Oswaldo Cruz, Sao Paulo, Brasil)

Evidence Based Medicine
Leonardo Roever, PhD (Federal University of Uberlandia (UFU), Minas Gerais, Brazil)

Women and Ischemic Heart Disease 
Arasi Maran, MD (Medical University of South Carolina, Charleston, South Carolina USA)

Statin Drugs
Matti J. Tikkanen, MD, PhD (University of Helsinki, Helsinki, Finland)

Non-statin Drugs
Rafael Carmena, MD, PhD, FACP, FRCP (University of Valencia, Valencia, Spain)